Cancer Risk Assessment of Germline TP53, MDM2 SNP309 and Sex in a Family Study of Li-Fraumeni Syndrome
碩士 === 國立成功大學 === 環境醫學研究所 === 106
Main Authors: | HsinHung, 洪昕 |
---|---|
Other Authors: | Chih-Chieh Wu |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/tkay5f |
Similar Items
-
Impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.
by: Yasuki Hori, et al.
Published: (2015-01-01) -
Correction: impact of TP53 codon 72 and MDM2 SNP 309 polymorphisms in pancreatic ductal adenocarcinoma.
by: PLOS ONE Staff
Published: (2015-01-01) -
Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome
by: Francesco Paduano, et al.
Published: (2021-09-01) -
The contribution of <it>CHEK2 </it>to the <it>TP53</it>-negative Li-Fraumeni phenotype
by: Ruijs Marielle WG, et al.
Published: (2009-02-01) -
Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
by: Shenying Fang, et al.
Published: (2010-05-01)